ABOUT
BLOG
CATEGORIES
CONTACT
PRIVACY POLICY
RESOURCES
REVIEWS
ABOUT
BLOG
CATEGORIES
CONTACT
PRIVACY POLICY
RESOURCES
REVIEWS
START HERE
✕
lecanemab
Home
lecanemab
November 29, 2022
Alzheimer’s drug may benefit some patients, new data shows
[ad_1] The drug lecanemab, made by Eisai and Biogen, also carries a risk of brain swelling and bleeding and should be investigated further, a report of the findings said. [ad_2] Source link
START HERE
This website uses cookies to improve your experience. By using this website you agree to our
Data Protection Policy
.
Read more
Accept all